Ron Bentsur - Apr 1, 2022 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chairman & CEO, Director, 10%+ Owner
Signature
/s/ Ron Bentsur
Stock symbol
NVCT
Transactions as of
Apr 1, 2022
Transactions value $
$0
Form type
4
Date filed
4/5/2022, 04:46 PM
Previous filing
Mar 29, 2022
Next filing
May 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Award $0 +120K +4.25% $0.00 2.95M Apr 1, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units will vest according to the following schedule: one-third on each of 4/1/2023, 4/1/2024, and 4/1/2025.
F2 Includes 96,759 shares of restricted stock and 120,000 restricted stock units.